To advance scientific knowledge and develop treatments and cures for breast cancer, the Extramural Grants Administration Program staff will issue requests for applications on behalf of the Health Research Science Board. Check this web site for updates, or sign up for HRSB eAlerts and indicate Request for Application (RFA) as your area of interest.
Click here for tips on managing graphics and file sizes submitted with your RFA or RFP.
Funding Opportunities Pending Review
-
Patricia S. Brown Breast Cancer Risk Reduction Education Research Projects (Round 5) RFA
-
Peter T. Rowley Breast Cancer Scientific Research Projects (Round 4) RFA
-
Healthcare Practitioner Breast Cancer Education Research Projects (Round 1) RFA
Recent Awards
- Peter T. Rowley Breast Cancer Scientific Research Projects RFA (Round 3). These projects are two-year awards.
| Principal Investigator | Sponsoring Institution | Amount | Title |
|---|---|---|---|
| Chia-Hsin Chan, Ph.D. | The Research Foundation for SUNY Stony Brook | $359,999 | A New Strategy and Tool to Tackle Cancer Stem Cells and Metastasis in Triple-negative Breast Cancer |
|
Mikala Egeblad, Ph.D. |
Cold Spring Harbor Laboratory | $345,800 | Modulating Innate-adaptive Immune Cell Interactions for the Immunotherapy of Breast Cancer |
| Sharon S. Evans, Ph.D. | Health Research Incorporated, Roswell Park Cancer Institute | $360,000 | Novel Mechanism of Immune Subversion by Myeloid-Derived Suppressor Cells in Aggressive Breast Cancer |
| John G. Frelinger, Ph.D. | University of Rochester | $357,747 | Amplifying Immune Responses to Breast Cancer Using a Novel IL.2 Therapy to Limit Side Effects and Enhance Efficacy |
| David Jeruzalmi, Ph.D. | The Research Foundation of CUNY obo City College of New York | $347,200 | Laying the Foundation for Combination Therapy Against Breast Cancer: Analysis of Human Shelterin-DNA Complex |
| Mira Krendel, Ph.D. | The Research Foundation for SUNY Upstate Medical University | $360,000 | Myosin 1e as a Potential Therapeutic Target in Breast Cancer |
| Juntao Luo, Ph.D. | State University of New York Upstate Medical University | $360,000 | Structure-based Nanocarrier Design for Targeted Cabazitaxel Delivery to the Advanced Breast Cancer Brain Metastases |
| Mark Noble, Ph.D. | University of Rochester | $359,907 | Safer and More Effective Treatment of Luminal Breast Cancer and Overcoming Tamoxifen Resistance |
|
Scott Powers, Ph.D. |
The Research Foundation for SUNY Stony Brook | $350,302 | Single-cell Barcoding to Study Breast Cancer Evolution and Drug Resistance |
|
Robert J. Schneider, Ph.D. |
New York University School of Medicine | $360,000 | Reversing Tamoxifen Resistance in Estrogen Receptor Positive Breast Cancer |
- Peter T. Rowley Breast Cancer Research Project and Postdoctoral Fellowship Awards RFA (Round 2): A total of $3,597,800 million in Peter T. Rowley Breast Cancer Research Project and Postdoctoral Fellowship Awards RFA awards were made in 2011, providing initial support for preliminary testing of novel or exploratory hypotheses related to breast cancer. Recipients are expected to open a new area of investigation, satisfactorily test a novel hypothesis, or produce viable data for preparation of a full-scale research application to another organization. Awards were made to eight investigators, with a maximum of $360,000 for two-year projects.
| Principal Investigator | Sponsoring Institution | Amount | Title |
|---|---|---|---|
| Anne R. Bresnick, Ph.D. | Albert Einstein College of Medicine | $360,000 | Stromal Contribution of the S100A4 Metastasis Factor to Tumor Invasion |
| Pamela Cowin, Ph.D. | New York University School of Medicine | $360,000 | The Role of Gpr 125 in Breast Development and Cancer |
| Johanna A. Joyce, Ph.D. | Sloan-Kettering Institute for Cancer Research | $360,000 | Investigating and Targeting Interactions Between Cancer and the Microenvironment in Breast to Brain Metastasis |
| Paraic A. Kenny, Ph.D. | Albert Einstein College of Medicine | $360,000 | Consequences of GATA3 Mutation for Normal Mammary Gland Development and Breast Cancer |
| Xiaojing Ma, Ph.D. | Weill Cornell Medical College | $360,000 | Targeting CCL5 in Triple Negative Breast Cancer |
| Jeffrey W. Pollard, Ph.D. | Albert Einstein College of Medicine | $360,000 | Macrophages and Immunosuppression in Breast Cancer |
| Elizabeth A. Repasky, Ph.D. | Roswell Park Cancer Institute | $357,000 | Is the Immune Response Against Breast Cancer Inhibited by Lack of Available Metabolic Energy? |
| Rodney Rothstein, Ph.D. | Columbia University | $360,000 | Developing a New Paradigm to Discover Novel Breast Cancer Drug Targets |
Print